Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIEGE: Abraxane and Gemcitabine Schedules in Metastatic Pancreatic Cancer
NCT03529175Phase 2Completed
- Sponsor
- Cambridge Clinical Trials Unit
- Start
- Jan 2014
- Primary completion
- Jun 2016
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in pancreatic adenocarcinoma (PDAC), sponsored by Cambridge Clinical Trials Unit. Started Jan 2014; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03529175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03529175.